Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2010
09/16/2010US20100234364 Ccr2 inhibitors and methods of use thereof
09/16/2010US20100234363 Heterocyclic derivative having inhibitory activity on type-i 11 data-hydroxysteroid dehydrogenase
09/16/2010US20100234362 Use of diazoxide for suppressing the plasma insulin level in a mammal
09/16/2010US20100234361 Selected cgrp-antagonists, process for preparing them and their use as pharmaceutical compositions
09/16/2010US20100234360 Methods for Regulating Neurotransmitter Systems by Inducing Counteradaptations
09/16/2010US20100234359 Treatment of sleep disorders
09/16/2010US20100234358 Neramexane for the treatment of nystagmus
09/16/2010US20100234357 Benzofuran derivatives
09/16/2010US20100234356 Compounds useful as chemokine receptor antagonists
09/16/2010US20100234355 Isoquinoline derivatives and their use as inhibitors of cytokine mediated diseases
09/16/2010US20100234354 Pyridazinone derivatives
09/16/2010US20100234353 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
09/16/2010US20100234352 Factor xa inhibitors
09/16/2010US20100234351 Fused nitrogen-comprising heterocyclic compound
09/16/2010US20100234350 Platelet adp receptor inhibitors
09/16/2010US20100234349 Pharmaceutical combinations of a nicotine receptor modulator and a cognitive enhancer
09/16/2010US20100234348 Compositions and methods for potentiating antibiotic activity
09/16/2010US20100234347 Substituted Pteridines substituted with a Four-Membered Heterocycle
09/16/2010US20100234346 Novel pyrimidine derivatives
09/16/2010US20100234345 Novel compounds as cannabinoid receptor ligands
09/16/2010US20100234344 8-oxy-quinoline derivatives as bradykinin b2 receptor modulators
09/16/2010US20100234343 Inhibitors of ion channels
09/16/2010US20100234342 Ezetimibe compositions
09/16/2010US20100234341 Substituted pyrimidines as adenosine receptor antagonists
09/16/2010US20100234340 Substituted Spiroamide Compounds
09/16/2010US20100234339 Silver(i) compounds and their use in pharmaceutical compositions for the treatment,prophylaxis and prevention of infections
09/16/2010US20100234338 Chelating agents of metal ions, their methods of preparation and their applications
09/16/2010US20100234337 Foaming compositions for hair care
09/16/2010US20100234336 Ophthalmic Compositions
09/16/2010US20100234335 Neurosteroid compounds
09/16/2010US20100234334 Nitric oxide releasing steroids
09/16/2010US20100234333 Novel quinuclidine derivatives and medicinal compositions containing the same
09/16/2010US20100234332 Novel quinuclidine derivatives and medicinal compositions containing the same
09/16/2010US20100234331 Hexahydro-cyclooctyl pyrazole cannabinoid modulators
09/16/2010US20100234330 Novel Estrogenic Compounds
09/16/2010US20100234329 Ingestible film composition
09/16/2010US20100234328 Antimicrobial Compositions And Related Methods
09/16/2010US20100234327 Novel Triazene Compounds For The Treatment Of Cancer
09/16/2010US20100234326 Composition for decelerating the aging in the organism and for extending the life time thereof and the use of said composition
09/16/2010US20100234325 4-Peroxycyclophosphamide use thereof
09/16/2010US20100234324 Quinazolinamide derivatives
09/16/2010US20100234323 Antimicrobial Acids and Salts
09/16/2010US20100234322 Treatment of osteoarthritis
09/16/2010US20100234320 Emulsifying compositions based on alkyl polyglycosides and esters
09/16/2010US20100234319 Complex of Polymeric Quaternary Ammonium and Anionic Polymers as a New Antimicrobial Agent for Ophthalmic Compositions
09/16/2010US20100234318 Ophthalmic composition containing alginic acid or salt thereof
09/16/2010US20100234317 Use of difructose anhydride-containing composition
09/16/2010US20100234316 Nucleoside Aryl Phosphoramidates for the Treatment of RNA-Dependent RNA Viral Infection
09/16/2010US20100234315 Compositions and methods for treating psychiatric and behavioral disorders
09/16/2010US20100234314 Idarubicin for the treatment of lymphoma in a dog
09/16/2010US20100234313 Stabilized micronised particles
09/16/2010US20100234311 Methicillin-Resistant Staphylococcus Aureus Active Metabolites
09/16/2010US20100234310 Estrogenic compounds and their methods of use
09/16/2010US20100234309 Dendrimer Compositions
09/16/2010US20100234307 Preparation and use of biphenyl amino acid derivatives for the treatment of obesity
09/16/2010US20100234297 Soluble Fiber Combinations for Weight Control and Improving Parameters of Cardiovascular Health
09/16/2010US20100234295 Treating Alzheimer's Disease And Osteoporosis And Reducing Aging
09/16/2010US20100234294 Identification of new isoforms of the mhc-class i specific receptor cd160 and uses thereof
09/16/2010US20100234293 Novel Neurotrophic Factors
09/16/2010US20100234289 Integrin binding rgd-lipopeptides with gene transfer activities
09/16/2010US20100234288 SUSTAINED RELEASE PHARMACEUTICAL COMPOSITION ON THE BASIS OF RELEASE SYSTEM COMPRISING AN ACID-SOLUBLE POLYMER AND A pH-DEPENDENT POLYMER
09/16/2010US20100234286 Preterm formula
09/16/2010US20100234285 Benzofuranyl Derivatives
09/16/2010US20100234282 System for delivering nucleic acids for suppressing target gene expression by utilizing endogenous chylomicron
09/16/2010US20100234233 Polymer hydrogels and methods of preparation thereof
09/16/2010US20100234219 Isoxazolines for Controlling Invertebrate Pests
09/16/2010US20100233810 In vivo production of small interfering rnas that mediate gene silencing
09/16/2010US20100233735 Pharmaceuticals and methods for treating hypoxia and screening methods therefor
09/16/2010US20100233728 Method and kit for detecting the early onset of renal tubular cell injury
09/16/2010US20100233690 Use of genes identified to be involved in tumor development for the development of anti-cancer drugs and diagnosis of cancer
09/16/2010US20100233306 Methods and compositions for weight loss using garcinia indica fruit puree
09/16/2010US20100233304 Compositions comprising unsaturated fatty acids and nitric oxide releasing compounds and use thereof for enhancing cognitive and related functions
09/16/2010US20100233297 Systemic administration of nac as an adjunct in the treatment of terrorism exposures such as radiation and for prophylaxis
09/16/2010US20100233296 Method and system for producing a substance or a signal with a coagulating or anticoagulant effect
09/16/2010US20100233295 Aqueous moisturizers and lubricants and uses thereof
09/16/2010US20100233294 Use of tellurium compounds for inhibition of interleukin-converting enzyme
09/16/2010US20100233293 Phosphaplatins and their use in the treatment of cancers resistant to cisplatin and carboplatin
09/16/2010US20100233290 Use of difructose anhydride-containing composition
09/16/2010US20100233280 Omega-3 enriched fish oil-in-water parenteral nutrition emulsions
09/16/2010US20100233279 Compositions And Methods Comprising Analogues Of Radicicol A
09/16/2010US20100233278 Rapidly disintegrating solid preparation
09/16/2010US20100233277 Biodegradable polymer scaffold and process for preparation thereof
09/16/2010US20100233275 Process for preparing lipid nanoparticles
09/16/2010US20100233272 Dosage forms comprising celecoxib providing both rapid and sustained pain relief
09/16/2010US20100233271 Slow release of organic salts of local anesthetics for pain relief
09/16/2010US20100233268 Powder formulations for inhalation containing enantiomerically pure beta-agonists
09/16/2010US20100233267 Composite hydrogel
09/16/2010US20100233266 Articles and methods of treating vascular conditions
09/16/2010US20100233265 Matrix-type pharmaceutical solid preparation
09/16/2010US20100233264 TEMPERATURE AND pH-SENSITIVE BLOCK COPOLYMER HAVING EXCELLENT SAFTY IN VIVO AND HYDROGEL AND DRUG DELIVERY SYSTEM USING THEREOF
09/16/2010US20100233263 Methods and compositions for treatment of lesioned sites of body vessels
09/16/2010US20100233262 Coated tablet
09/16/2010US20100233261 Pharmaceutical Composition Comprising Amlodipine and Losartan
09/16/2010US20100233260 Pharmaceutical composition for oral administration
09/16/2010US20100233259 Dosage form of ropinirole
09/16/2010US20100233258 Tablet having concavity with active ingredient disposed therein and manufacturing method thereof
09/16/2010US20100233257 Low dose sublingual tablets of opioid analgesics and preparation process
09/16/2010US20100233256 Synergistic combinations for treating hypertension
09/16/2010US20100233255 Combination of trazine derivatives and insulin secretion stimulators
09/16/2010US20100233253 Extended release gastro-retentive oral drug delivery system for valsartan
1 ... 2089 2090 2091 2092 2093 2094 2095 2096 2097 2098 2099 2100 2101 2102 2103 2104 2105 2106 2107 2108 2109 ... 7860